France’s assisted dying law clears parliament in a 291-241 vote, ending a decade of deadlock

France’s National Assembly adopted the final text of a long-debated right-to-die bill on Tuesday 15 July 2026, voting 291 in favour and 241 against to allow adults suffering from incurable illness to request a lethal prescription. The measure, cleared after years of stalled attempts, marks the most significant change to French end-of-life law since the 2016 Claeys-Leonetti framework and puts the country in line with Belgium, the Netherlands, Luxembourg and Spain, where similar provisions already exist.

The vote resolves a deadlock that had stretched across three presidencies. It also lands at a moment when the question of how societies legislate for dying has migrated from private ethics into mainstream party politics across much of Western Europe, with bills either on the table or recently enacted in Westminster, the Bundestag and the Cortes Generales. France’s decision is unlikely to be the last in this cycle.

What the bill actually does

The text, in the version adopted by the Assembly, restricts eligibility to adults with a serious and incurable condition that causes constant and unbearable physical or psychological suffering that cannot be relieved. Two physicians must confirm the diagnosis, and a third independent expert must be consulted before any prescription can be written. The substance is administered by the patient, on French soil, within a strictly defined window. Children and adults under guardianship are excluded from the mechanism, a carve-out that reflects a compromise negotiated inside the majority.

The framing in the final text borrows heavily from existing palliative-care language rather than introducing a parallel track. That choice matters: it allows the bill to be read as an extension of the Léonetti tradition rather than a rupture with it, a positioning that helped bring sceptical voices inside the centre-right Les Républicains onside. The Council of State had reviewed earlier drafts and flagged the eligibility criteria as the single point most likely to be challenged; the final wording tightens that clause and adds the third-physician safeguard.

The politics of the coalition

The vote exposed fault lines inside Emmanuel Macron’s centrist bloc as cleanly as it did inside the opposition. The presidential Ensemble alliance did not arrive at the hemicycle with a unified position. A minority of deputies broke with the majority to vote against; a smaller group abstained. In the ranks of the Rassemblement National, the picture was equally fractured, with Marine Le Pen permitting a free vote and senior figures landing on both sides of the lobby.

That a bill of this moral gravity passed on a freely voted conscience motion, rather than through a whipped party line, is itself a feature of the outcome worth pausing on. The government did not table the text as its own; the Assembly took ownership of the vehicle, and a cross-party group of sponsors shepherded it through. Prime minister Elisabeth Borne, who has backed the principle since her time as a backbencher, welcomed the result from the front bench without claiming authorship.

The left, fractured between the insoumis and the communists during the first reading, closed ranks more visibly in the final vote, lending the tally some of the margin it needed. Insoumise deputies who had abstained on earlier drafts voted in favour after the third-physician safeguard was added.

How France got here

The 2016 Claeys-Leonetti law deepened the right to deep, continuous sedation until death for patients at the end of life. It stopped short of authorising lethal prescriptions and explicitly rejected the term "assisted suicide" as defined in Belgium or Oregon. Eight years of clinical practice, and an estimated several thousand requests for assistance that the existing law could not meet, created the constituency for change.

A citizens’ convention on the question, convened in late 2022 and modeled on the prior climate convention, recommended by a large majority that the legislature extend the framework to allow a lethal prescription under tightly drawn conditions. President Macron endorsed the principle in a televised address in March 2023 and instructed the government to draft enabling legislation. That draft, deposited in the spring of 2024, was overtaken by the dissolution of the National Assembly and the snap election campaign that followed.

The legislative calendar was reset when the new Assembly convened. Cross-party sponsors took ownership of the file and absorbed many of the recommendations of a follow-up parliamentary commission. What returned to the hemicycle in 2026 is closer to a parliamentary text than a government bill.

What remains contested

Two points will not be settled by Tuesday’s vote. The first is palliative care. Watchdog bodies inside the medical profession have argued throughout the debate that the existing Léonetti framework is under-implemented; that a serious state commitment to universal access to palliative care must precede any move to authorise lethal prescriptions. The bill as adopted does not separate the two tracks and does not, in its current form, guarantee funding levels for palliative services in the regions where they are scarcest. The government has signalled that a follow-up financing instrument will be tabled, but has not yet done so.

The second point is the conscience clause. French physicians are not obliged to take part in the procedure, and must be able to direct the patient to a colleague willing to do so. The practical mechanics of that referral, particularly in rural departments and overseas territories where the relevant specialties are thin on the ground, are still being negotiated with the Ordre des Médecins. The Council of State will have the final word on the implementing decrees.

Sovereignty over the end of life sits with national parliaments. There is no question of European-level harmonisation, and the European Court of Human Rights has consistently left the substantive question to member states. That leaves France free to legislate as it sees fit, but also responsible for the entire downstream architecture: drug supply, training, regional access, palliative co-financing, and the long-term clinical follow-up that the Belgian and Dutch systems have spent twenty years refining.

A reasonable working assumption is that the law will enter into force on a phased schedule over the next eighteen to twenty-four months, with the first prescriptions authorised in early 2027 if the implementing decrees arrive on time. The first prosecution, the first contested refusal, the first regional access dispute and the first budgetary decision on palliative care will each be tests in their own right. The legislative door is now open. The administrative work begins on Wednesday.

This publication’s coverage of France’s end-of-life debate has foregrounded the parliamentary arithmetic and the conservative carve-outs, rather than the more familiar framing of a country "catching up" with its neighbours. The legislative history matters: this was a parliamentary text that succeeded where government-sponsored drafts had stalled, and the bill’s substance is closer to a tightening of the Léonetti framework than to a Belgian-style regime.

Wire provenance

This editorial synthesis draws on the following public wire/social posts:

• https://t.me/osintlive
• https://en.wikipedia.org/wiki/End-of-life_care_in_France